Post by
goldtech on Aug 16, 2023 12:55pm
TSE LISTING
Now it shows the acumen of this management team. Going off the TSE and spending millions acquiring a new CEO that has done nothing and keeping this lame board has cost the shareholders their longtime dreams of having a cure for AD. All time lows for PMN and you say what best in class. Worst management team ever and the greedy will prevail.
Comment by
M101 on Aug 16, 2023 1:45pm
This board will lose this cushy gig if it goes private, but it is just gig work in a revolving door gig system designed for failing upward. Of course I'm not suggesting they're getting paid to kill this company, I'm just saying it looks that way right now because at least two big pharmas would stand to benefit.